Bioproduction is the production of industrially or medically important products by using natural or recombinant cells or living systems such as bacteria, virus, yeast, animal cells, plant cells or transgenics. The end products d ....see more
The global 3D bioprinting market, valued at US$1.2B in 2023, is forecasted to grow at a 12.7% CAGR, reaching US$1.3B by 2024 and US$2.4B by 2029. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
The global biologics safety testing market, valued at US$3.9B in 2023, is forecasted to grow at a 11.1% CAGR, reaching US$4.2B by 2024 and US$7.2B by 2029. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry.
The global pyrogen testing market growth is primed to transition from $927 million in 2020 to $1,689 million by 2025, showcasing a strong CAGR of 12.7%. Market drivers include increasing demand for personalized medicine, R&D in pharmaceuticals and biotechnology, rising chronic and infectious diseases, and growing awareness of food safety.
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 212.1 Million in 2016, at a CAGR of 14.4% from 2016 to 2021. Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).
The global downstream processing market is projected to grow at a CAGR of 16.4%. In this report, the global downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region.